|
Friday 30th July 2021 |
Text too small? |
Further to advice provided on 3 June 2021, regarding difficulties with trading in the first half of FY22 (1H22: Feb to July 21), NZK is now able to be more specific on full year guidance.
The 2022 earnings forecast of proforma EBITDA is in the range of $8.0m to $10.0m, the majority to be generated in 2H22.
Fish size, which was a problem in the first half due to a one-off issue with the model, has now recovered and biomass is on track for a satisfactory position in October 2021. Price increases have also been implemented.
A hearing date has been established for the open ocean farming consent application, named “Blue Endeavour”, in October 2021, which has the potential to generate significant supply in future years.
Please see the link below for details
Source: New Zealand King Salmon Investments Limited
No comments yet
HGH Ltd Results for the 6 months ended 1 February 2026
March 27th Morning Report
CDC investor presentation and guidance update
PFI - Potential Bond Offer by PFI
MCY - Mercury Green Bond offer - interest rate set
March 25th Morning Report
AFT - Chief Financial Officer update
KMD Brands: Response to Stokehouse transaction concept
March 24th Morning Report
MCY - Mercury launches retail Green Bond offer